The Roundtable (25/03/2022), chaired by Gitta Vanpeborgh, Belgian Federal Deputy, was well-attended with strong engagement from participants. Hanne Sanders, Adviser on Wellbeing and Safety at Work to Cabinet of the Deputy Prime Minister and Ministry of the Economy and Labour… Read more
News
Mental and Psychosocial Health in Healthcare; Preventing Medication Errors and Adverse Events and Disorders in Healthcare Workers
Aims and Objectives Improving the mental and psychosocial health and wellbeing of healthcare workers by understanding the causes and effects and preventing mental and psychosocial health disorders and adverse events , mainly medication errors; and by implementing traceability systems and… Read more
Highlights of the outcome of CMD4 and the new provisions of the Carcinogens, Mutagens and Reprotoxins Directive
Inclusion of reprotoxic substances in the scope of the new Carcinogens, Mutagens and Reprotoxins Directive (CMRD). For 12 of these substances, a binding occupational maximum exposure level limit value will be introduced in Annex III of the Directive. Inclusion of… Read more
Stop Cancer at Work Campaign welcomes progress made in protecting workers from cancer and reproductive problems at work
The Stop Cancer at Work Campaign today welcomes the provisional political agreement by the European Parliament and European Council to include for the first time greater protection and reference to reprotoxic substances and hazardous medicinal products (HMPs) in the fourth… Read more
Hazardous Drugs: Guide to Surface Monitoring
Nurses must have the greatest individual protection during the handling of hazardous drugs, guaranteeing at the same time adequate patient care, and must also be informed and trained on the risks associated with the activity they carry out, taking… Read more
ANSES report to the French government
The French health and safety agency ANSES has just published its report to the French government recommending the inclusion in French national legislation and the CMD of a list of cytostatic, or carcinogenic, drugs and agents (HMPs). They also… Read more
Stop Cancer at Work Campaign calls on European Commission to approve legislation
The Stop Cancer at Work (SCAW) Campaign calls on the European Commission to approve legislation now to protect workers and patients from getting cancer. The trilogue process with the European Council, Parliament and Commission under the Portuguese Presidency concludes today… Read more
EBN Webinar: Preventing sharps injuries, MDR and safety mechanism in medical devices
This morning the European Biosafety Network hosted a webinar on preventing sharps injuries, the MDR and safety mechanisms in medical devices. The webinar was attended by over 30 people with representation from healthcare employers, healthcare unions, expert medical professionals, inspection… Read more
European healthcare workers suffered an increase of 276,000 sharps injuries due to COVID-19
New research published today from Ipsos MORI, on behalf of the European Biosafety Network, reveals that COVID-19 led to an increase of 276,000 (23%) in the number of sharps injuries to healthcare workers in Europe over the last year. The… Read more
Stop Cancer at Work Briefing Note on Inclusion of HMPs and Reprotoxins in the CMD
Every year more than 12.7 million healthcare workers in Europe are potentially exposed to carcinogenic, mutagenic and reprotoxic hazardous drugs (also known as hazardous medicinal products or HMPs). Studies show that hospital workers who handle cytotoxic (antineoplastic) drugs, used to… Read more
